News Release

Near Miss Dosing Error for Unapproved Drug Used to Hasten COVID Recovery

The Institute for Safe Medication Practices (ISMP) special edition of the ISMP Medication Safety Alert!® acute care newsletter this week provides information on an error-prone dose expression on the label of an unapproved drug, ascorbic acid, that is being used to hasten recovery in COVID-19 patients. It also presents highlights from a Clinician Outreach and Communication Activity (COCA) webinar on the response of two health systems to the pandemic.

In addition, the fifth special edition includes insight and tips on:

  • Identifying drugs used to treat COVID-19 that may cause heart arrhythmias

  • National Institutes of Health (NIH) study on decontamination of N95 respirators

  • Warning patients not to take invermectin products meant for animals to “cure” COVID-19

  • Healthcare professionals tripping on IV extension set tubing when pumps placed in hallways

The special edition newsletters are being made available for free to the general public as well as subscribers. To access a copy, click here. Please note that access may require free registration.

More News

Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue